Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Status:
Recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
Osteoporosis affects 24.5% of women over 65 and results in fracture-related hospital
admissions exceeding those of heart attacks, strokes and breast cancer combined. Current
treatment options do not account for differences between age-related and estrogen deficiency
related osteoporosis, because of the need for bone biopsies for determination. This study
will establish a paradigm-shifting individualized treatment protocol for age-related
osteoporosis and a non-invasive method for its determination, thereby reducing the major
health problems and enormous burden on society and the elderly related to this disease.